Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma
- Drug Resist. Update, Available online 17 January 2024 | https://doi.org/10.1016/j.drup.2024.101054